▁St 10.375
. 3.93359375
▁J 6.0703125
ude 0.431396484375
▁Medical 4.25
▁Inc 3.072265625
' 6.51953125
s 0.0897216796875
▁third 6.62890625
- 0.71142578125
qu 0.2413330078125
arter 0.00543212890625
▁prof 4.6328125
its 0.0263824462890625
▁held 6.98828125
▁back 5.4296875
▁by 0.4375
▁missed 7.83984375
▁heart 8.5546875
▁val 4.29296875
ve 0.0186004638671875
▁sale 6.09375
▁to 4.25
▁Iran 9.6953125
▁and 3.767578125
▁other 3.8671875
▁factors 2.958984375
<0x0A> 3.28125
St 3.310546875
. 0.52783203125
▁J 0.09033203125
ude 0.00014293193817138672
▁Medical 0.347900390625
▁Inc 0.428955078125
, 3.04296875
▁a 1.3046875
▁leading 2.6171875
▁global 2.302734375
▁medical 0.6591796875
▁device 0.44189453125
▁manufact 1.541015625
urer 0.035369873046875
, 0.41796875
▁recently 5.31640625
▁released 2.421875
▁its 0.427734375
▁financial 2.412109375
▁report 2.296875
▁for 0.35205078125
▁the 0.172119140625
▁third 0.25537109375
▁quarter 0.2093505859375
▁of 0.5048828125
▁the 2.111328125
▁year 0.69921875
. 0.97802734375
▁While 4.4453125
▁the 0.4384765625
▁company 1.08984375
▁reported 2.6171875
▁overall 5.1484375
▁growth 3.48828125
, 1.2958984375
▁there 3.1015625
▁were 0.302001953125
▁certain 3.841796875
▁factors 1.9951171875
▁that 0.300537109375
▁impact 2.30859375
ed 0.006000518798828125
▁its 1.095703125
▁prof 2.12890625
its 0.0010938644409179688
▁during 4.52734375
▁this 1.7275390625
▁period 0.83447265625
, 3.46484375
▁most 4.30859375
▁not 0.343505859375
ably 0.0006046295166015625
▁a 1.85546875
▁missed 0.84716796875
▁heart 1.26171875
▁val 0.0118865966796875
ve 0.0006837844848632812
▁sale 0.161376953125
▁to 0.1314697265625
▁Iran 0.151123046875
. 0.95556640625
▁In 3.361328125
▁addition 0.724609375
, 0.23193359375
▁other 3.212890625
▁factors 0.4755859375
▁such 1.9609375
▁as 0.006183624267578125
▁economic 5.1015625
▁challeng 4.09375
es 0.0014638900756835938
▁and 1.244140625
▁product 5.2890625
▁rec 3.02734375
alls 0.0008606910705566406
▁also 1.8681640625
▁contributed 2.271484375
▁to 0.06707763671875
▁the 0.6494140625
▁less 7.2890625
- 1.119140625
than 0.003734588623046875
- 0.01282501220703125
expected 0.82568359375
▁financial 2.896484375
▁performance 0.9541015625
. 0.5712890625
<0x0A> 0.57080078125
I 5.1171875
ran 0.47216796875
, 3.0390625
▁with 5.6015625
▁its 1.275390625
▁growing 2.8671875
▁population 1.9345703125
▁and 0.54736328125
▁increasing 2.064453125
▁demand 1.595703125
▁for 0.0121002197265625
▁medical 0.53125
▁devices 0.369873046875
, 0.232666015625
▁has 1.36328125
▁become 1.4814453125
▁an 1.6943359375
▁important 0.275390625
▁market 0.234130859375
▁for 0.02972412109375
▁many 3.701171875
▁health 4.87109375
care 0.236083984375
▁companies 0.367919921875
. 0.37841796875
▁St 0.982421875
. 0.005123138427734375
▁J 0.00415802001953125
ude 4.661083221435547e-05
▁Medical 0.06414794921875
▁Inc 1.1396484375
▁had 3.1953125
▁been 1.4140625
▁eye 2.921875
ing 0.00013637542724609375
▁this 0.68212890625
▁opportunity 2.357421875
▁and 1.1376953125
▁had 0.93359375
▁inv 4.765625
ested 1.9550323486328125e-05
▁significant 2.537109375
▁resources 0.345947265625
▁in 0.74267578125
▁developing 0.98681640625
▁relationships 5.21484375
▁and 1.697265625
▁establish 2.611328125
ing 0.0015077590942382812
▁a 1.4853515625
▁strong 2.57421875
▁presence 0.22998046875
▁in 0.1361083984375
▁the 0.69091796875
▁country 0.74267578125
. 0.055206298828125
▁However 0.72705078125
, 0.00136566162109375
▁due 2.029296875
▁to 0.0008106231689453125
▁un 3.041015625
for 0.53564453125
ese 0.004669189453125
en 0.00894927978515625
▁circumstances 0.54296875
, 0.10968017578125
▁the 0.36962890625
▁company 0.11224365234375
▁was 0.525390625
▁unable 0.45263671875
▁to 0.0007047653198242188
▁final 2.169921875
ize 0.01050567626953125
▁a 1.767578125
▁major 4.4765625
▁heart 1.6259765625
▁val 0.007633209228515625
ve 0.0004944801330566406
▁sale 0.2259521484375
▁to 0.2470703125
▁Iran 0.333740234375
▁during 3.537109375
▁the 0.265380859375
▁third 0.306884765625
▁quarter 0.00846099853515625
. 0.7314453125
▁This 1.2880859375
▁missed 3.02734375
▁opportunity 0.139404296875
▁affected 3.919921875
▁the 0.5849609375
▁company 0.189697265625
' 0.030792236328125
s 0.00055694580078125
▁re 2.923828125
venue 0.00022900104522705078
▁pro 4.54296875
jections 0.0013065338134765625
▁and 0.80029296875
▁h 6.6875
inder 0.0699462890625
ed 9.548664093017578e-05
▁its 0.13916015625
▁profit 4.22265625
▁growth 2.662109375
▁for 2.255859375
▁the 0.07135009765625
▁period 1.8310546875
. 0.09649658203125
<0x0A> 0.1488037109375
The 1.67578125
▁reasons 8.328125
▁behind 0.8271484375
▁the 0.81689453125
▁missed 0.190673828125
▁heart 1.9619140625
▁val 0.00374603271484375
ve 0.0004088878631591797
▁sale 0.056610107421875
▁remain 4.6015625
▁unclear 0.572265625
, 1.3330078125
▁but 0.2001953125
▁it 0.80517578125
▁is 0.53125
▁believed 1.3310546875
▁that 0.2122802734375
▁ge 6.546875
opol 0.00848388671875
it 3.266334533691406e-05
ical 0.0094146728515625
▁t 0.7529296875
ensions 0.02911376953125
▁and 2.44921875
▁regul 5.88671875
atory 0.00013458728790283203
▁un 3.69140625
cert 0.022735595703125
aint 5.638599395751953e-05
ies 7.808208465576172e-05
▁surrounding 4.0703125
▁Iran 2.318359375
' 1.7646484375
s 0.0001596212387084961
▁trade 6.81640625
▁relations 2.96875
▁may 2.28125
▁have 0.0273590087890625
▁played 0.689453125
▁a 0.0225067138671875
▁role 0.2056884765625
. 0.6865234375
▁San 11.0078125
ctions 0.062042236328125
▁and 2.201171875
▁trade 1.9833984375
▁restrictions 0.70947265625
▁im 1.7353515625
posed 4.363059997558594e-05
▁on 1.6435546875
▁Iran 0.1328125
▁by 0.8955078125
▁various 3.220703125
▁countries 0.3056640625
▁have 0.79541015625
▁created 3.580078125
▁a 1.583984375
▁complex 3.3203125
▁business 3.869140625
▁environment 0.05413818359375
, 2.048828125
▁making 1.08203125
▁it 0.06268310546875
▁challeng 2.451171875
ing 2.8252601623535156e-05
▁for 0.070556640625
▁companies 0.814453125
▁like 1.783203125
▁St 0.0031375885009765625
. 0.005809783935546875
▁J 0.0038909912109375
ude 7.724761962890625e-05
▁Medical 0.08782958984375
▁Inc 0.08270263671875
▁to 0.03851318359375
▁navigate 4.25390625
. 2.119140625
▁It 4.015625
▁is 0.312744140625
▁also 1.0400390625
▁worth 2.052734375
▁not 0.061553955078125
ing 0.0004372596740722656
▁that 0.002933502197265625
▁some 4.3671875
▁Western 6.6796875
▁companies 0.71630859375
▁have 0.638671875
▁faced 3.595703125
▁eth 9.7109375
ical 0.06732177734375
▁and 1.7216796875
▁legal 0.66650390625
▁d 6.51953125
ile 0.0052032470703125
mm 0.00437164306640625
as 2.1457672119140625e-06
▁when 1.7919921875
▁conduct 2.404296875
ing 0.0005145072937011719
▁business 0.026031494140625
▁in 0.276611328125
▁countries 1.904296875
▁subject 6.7109375
▁to 0.057769775390625
▁san 0.438232421875
ctions 0.0095062255859375
, 2.703125
▁which 1.544921875
▁might 4.9296875
▁have 0.11260986328125
▁fact 6.7578125
ored 5.8770179748535156e-05
▁into 0.05169677734375
▁the 0.47119140625
▁decision 0.6591796875
- 3.056640625
making 0.002880096435546875
▁process 0.0300750732421875
. 0.80029296875
<0x0A> 0.1717529296875
A 5.4140625
part 1.0478515625
▁from 0.0005879402160644531
▁the 0.5751953125
▁missed 0.35107421875
▁opportunity 2.8203125
▁in 1.9033203125
▁Iran 1.0107421875
, 0.0244598388671875
▁St 1.224609375
. 0.011688232421875
▁J 0.0027027130126953125
ude 0.00011420249938964844
▁Medical 0.0294036865234375
▁Inc 0.05596923828125
▁faced 2.337890625
▁other 0.86328125
▁challeng 0.1947021484375
es 0.00731658935546875
▁that 4.62109375
▁impact 0.92138671875
ed 0.0009183883666992188
▁its 0.06243896484375
▁financial 1.037109375
▁performance 0.05084228515625
▁in 1.9619140625
▁the 0.09857177734375
▁third 0.135498046875
▁quarter 0.0038471221923828125
. 0.25390625
▁The 1.888671875
▁on 5.91796875
going 0.03729248046875
▁global 3.525390625
▁economic 0.3212890625
▁slow 0.74560546875
down 0.00099945068359375
, 1.4189453125
▁couple 1.5439453125
d 0.0001863241195678711
▁with 0.0013303756713867188
▁uncertain 5.8046875
▁re 5.296875
imb 0.137939453125
urs 3.457069396972656e-05
ement 0.0150146484375
▁policies 1.345703125
▁in 1.556640625
▁certain 2.033203125
▁regions 3.181640625
, 0.161865234375
▁affected 4.5859375
▁the 0.91259765625
▁demand 4.109375
▁for 0.0157623291015625
▁medical 1.28515625
▁devices 0.044097900390625
. 0.6611328125
▁Health 8.046875
care 0.0819091796875
▁bud 5.6484375
gets 1.4901161193847656e-05
▁in 1.9267578125
▁several 3.130859375
▁countries 0.422607421875
▁were 1.181640625
▁under 1.5283203125
▁pressure 0.262939453125
, 0.85107421875
▁resulting 2.041015625
▁in 0.0007033348083496094
▁delayed 4.6640625
▁or 1.171875
▁can 0.67919921875
ce 0.0100555419921875
led 9.5367431640625e-07
▁orders 1.5029296875
▁for 1.1416015625
▁the 3.7890625
▁company 0.2156982421875
. 3.15625
▁Additionally 1.859375
, 0.0002429485321044922
▁unexpected 6.3515625
▁product 1.240234375
▁rec 0.03143310546875
alls 0.00012028217315673828
▁further 4.75390625
▁dis 5.25
rupted 0.0107421875
▁the 0.890625
▁sales 4.49609375
▁pipeline 2.322265625
▁and 1.1748046875
▁added 5.66796875
▁to 0.386962890625
▁the 0.4287109375
▁company 0.84765625
' 0.0009622573852539062
s 0.00017392635345458984
▁financial 1.8583984375
▁wo 1.0908203125
es 5.710124969482422e-05
. 0.1361083984375
<0x0A> 0.197265625
Product 8.203125
▁rec 0.1329345703125
alls 0.00020682811737060547
▁are 0.98828125
▁not 2.91796875
▁un 0.24169921875
common 0.0193328857421875
▁in 0.1884765625
▁the 0.045562744140625
▁medical 0.111083984375
▁device 0.1287841796875
▁industry 0.038482666015625
, 0.61767578125
▁as 2.71484375
▁safety 5.8515625
▁and 1.6669921875
▁quality 0.2919921875
▁are 1.013671875
▁param 1.65234375
ount 6.794929504394531e-05
. 0.7568359375
▁However 0.60791015625
, 0.0006403923034667969
▁they 3.146484375
▁can 0.435302734375
▁have 1.0849609375
▁a 0.3486328125
▁significant 0.77880859375
▁impact 0.11456298828125
▁on 0.0035343170166015625
▁a 0.92626953125
▁company 0.053802490234375
' 0.0086669921875
s 0.0002872943878173828
▁reputation 2.828125
▁and 0.25244140625
▁financi 5.94140625
als 0.0005726814270019531
. 0.287353515625
▁St 1.939453125
. 0.00411224365234375
▁J 0.00278472900390625
ude 4.7326087951660156e-05
▁Medical 0.00872039794921875
▁Inc 0.02911376953125
▁faced 2.482421875
▁such 4.81640625
▁a 0.463134765625
▁situation 0.55078125
▁during 1.578125
▁the 0.17822265625
▁third 0.076171875
▁quarter 0.0016078948974609375
▁when 1.7841796875
▁a 2.6953125
▁specific 6.50390625
▁range 7.19921875
▁of 0.0079345703125
▁its 0.93701171875
▁devices 3.880859375
▁had 4.56640625
▁to 0.11627197265625
▁be 0.0038089752197265625
▁re 0.341552734375
called 0.0009002685546875
▁due 0.5322265625
▁to 0.001186370849609375
▁potential 2.66015625
▁mal 3.91796875
function 1.2470703125
ing 1.4013671875
, 4.69140625
▁raising 6.8828125
▁concerns 0.9423828125
▁about 0.4326171875
▁patient 3.6171875
▁safety 0.0223236083984375
. 0.413818359375
▁The 1.4111328125
▁recall 2.1484375
▁necess 8.4453125
itated 0.0113525390625
▁additional 2.361328125
▁exp 2.30859375
enses 0.3173828125
▁for 2.447265625
▁the 0.62646484375
▁company 0.032928466796875
▁to 3.033203125
▁address 2.279296875
▁the 0.74267578125
▁issue 0.497314453125
▁and 0.966796875
▁impact 5.00390625
ed 0.0731201171875
▁sales 3.734375
▁as 3.76171875
▁customers 4.578125
▁opt 2.94140625
ed 0.0200347900390625
▁for 0.450439453125
▁alternative 1.15234375
▁products 0.955078125
▁or 2.109375
▁post 4.81640625
pon 0.006500244140625
ed 0.00298309326171875
▁purch 1.4345703125
ases 0.0457763671875
▁until 1.98046875
▁the 0.394775390625
▁situation 2.71484375
▁was 0.2412109375
▁resolved 0.07244873046875
. 0.0126953125
<0x0A> 0.1702880859375
Des 2.01171875
p 0.00045037269592285156
ite 3.6716461181640625e-05
▁these 0.8994140625
▁challeng 0.1956787109375
es 0.00919342041015625
, 0.032073974609375
▁St 0.2352294921875
. 0.0032501220703125
▁J 0.0011768341064453125
ude 8.20159912109375e-05
▁Medical 0.012664794921875
▁Inc 0.01070404052734375
▁reported 3.17578125
▁overall 1.892578125
▁growth 0.305908203125
▁in 0.6455078125
▁its 1.169921875
▁third 1.404296875
- 0.55078125
qu 0.0004839897155761719
arter 5.0187110900878906e-05
▁re 3.376953125
venue 3.8504600524902344e-05
, 1.1044921875
▁al 4.6875
beit 8.308887481689453e-05
▁at 1.205078125
▁a 0.1275634765625
▁slower 0.75390625
▁pace 0.25732421875
▁than 0.1859130859375
▁anticip 2.162109375
ated 3.8623809814453125e-05
. 0.10333251953125
▁The 0.374267578125
▁company 0.1744384765625
' 1.0439453125
s 4.267692565917969e-05
▁sales 2.75390625
▁rose 3.05078125
▁by 0.587890625
▁X 13.140625
% 0.677734375
▁compared 1.833984375
▁to 0.1566162109375
▁the 0.2093505859375
▁same 0.48291015625
▁period 0.25
▁last 0.454833984375
▁year 0.0004482269287109375
, 0.2822265625
▁reflect 3.822265625
ing 0.0028247833251953125
▁the 1.4072265625
▁on 3.03515625
going 0.013641357421875
▁demand 1.37109375
▁for 0.0181121826171875
▁its 0.4541015625
▁innov 4.546875
ative 0.00829315185546875
▁health 5.0859375
care 0.1580810546875
▁solutions 0.93994140625
. 0.340576171875
▁Moreover 3.455078125
, 0.0004324913024902344
▁its 1.951171875
▁gross 2.359375
▁margin 1.099609375
▁also 2.318359375
▁showed 4.6640625
▁improvement 1.4794921875
, 0.76953125
▁indicating 3.328125
▁successful 6.5859375
▁cost 1.2998046875
▁management 0.7666015625
▁strateg 2.361328125
ies 0.00012803077697753906
. 0.7607421875
▁However 2.1953125
, 0.0003268718719482422
▁the 0.85498046875
▁missed 5.31640625
▁heart 1.0654296875
▁val 0.0036773681640625
ve 0.0009593963623046875
▁sale 0.11297607421875
▁to 0.8740234375
▁Iran 0.00829315185546875
▁and 0.91064453125
▁the 3.0625
▁combination 10.2890625
▁of 0.084228515625
▁other 1.2294921875
▁factors 0.2432861328125
▁und 6.578125
ou 0.75830078125
bt 7.593631744384766e-05
edly 0.0011348724365234375
▁h 4.47265625
inder 0.00811767578125
ed 0.0006265640258789062
▁the 0.5302734375
▁company 0.137451171875
▁in 6.640625
▁ach 1.1005859375
ieving 1.3232231140136719e-05
▁its 0.1610107421875
▁full 2.05078125
▁profit 4.83984375
▁potential 0.360595703125
▁for 2.2890625
▁the 0.09295654296875
▁quarter 1.0810546875
. 0.08367919921875
<0x0A> 0.158935546875
Look 5.4296875
ing 0.0271759033203125
▁ahead 1.173828125
, 0.09844970703125
▁St 0.2890625
. 0.005420684814453125
▁J 0.001628875732421875
ude 8.07046890258789e-05
▁Medical 0.005611419677734375
▁Inc 0.006046295166015625
▁remains 3.029296875
▁optim 1.244140625
istic 0.00014066696166992188
▁about 0.1405029296875
▁its 0.1815185546875
▁long 2.76171875
- 0.0052642822265625
term 0.0018024444580078125
▁growth 1.0302734375
▁prospect 0.25537109375
s 0.0013141632080078125
, 1.431640625
▁with 1.994140625
▁potential 5.12890625
▁opportun 1.4853515625
ities 3.552436828613281e-05
▁in 0.63720703125
▁emer 1.623046875
ging 0.0003345012664794922
▁mark 0.10015869140625
ets 1.1920928955078125e-06
▁and 0.80859375
▁continued 2.703125
▁techn 5.7265625
ological 0.0025157928466796875
▁adv 0.7568359375
anc 0.1646728515625
ements 2.288818359375e-05
▁driving 4.4765625
▁innov 2.48046875
ation 0.08929443359375
▁in 1.66796875
▁the 1.0498046875
▁health 1.9970703125
care 0.022003173828125
▁industry 0.529296875
. 0.0169677734375
▁The 0.86279296875
▁company 0.0706787109375
▁is 1.39453125
▁continu 5.1484375
ously 1.13671875
▁invest 1.197265625
ing 0.0001024007797241211
▁in 0.046661376953125
▁research 1.0537109375
▁and 0.0281219482421875
▁development 0.006916046142578125
, 1.5703125
▁aim 3.0
ing 0.0987548828125
▁to 0.036895751953125
▁bring 2.96875
▁new 0.82275390625
▁products 0.75830078125
▁to 0.151611328125
▁market 0.365478515625
▁and 1.69140625
▁expand 1.6298828125
▁its 0.185791015625
▁global 1.8564453125
▁presence 1.2060546875
. 0.143798828125
▁However 4.23046875
, 0.0003056526184082031
▁it 1.7216796875
▁will 0.7939453125
▁need 2.0546875
▁to 0.04541015625
▁navigate 3.146484375
▁ge 5.53125
opol 0.0024662017822265625
it 5.9604644775390625e-06
ical 0.0018053054809570312
▁challeng 2.220703125
es 1.1920928955078125e-05
, 1.806640625
▁adapt 6.94921875
▁to 0.1632080078125
▁changing 0.5205078125
▁regul 2.201171875
atory 0.00012958049774169922
▁land 4.953125
sc 0.0002734661102294922
apes 0.00011038780212402344
, 0.259765625
▁and 0.046630859375
▁address 2.521484375
▁any 3.658203125
▁product 3.41015625
- 4.36328125
related 0.107421875
▁concerns 3.115234375
▁to 0.89892578125
▁ensure 2.712890625
▁sust 2.017578125
ain 0.583984375
able 0.00833892822265625
▁growth 0.302734375
▁and 1.8134765625
▁profit 0.69873046875
ability 0.009552001953125
▁in 1.1826171875
▁the 0.0911865234375
▁future 0.82958984375
. 0.01093292236328125
